OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 16, 2018
Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 08, 2018
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
May 07, 2018
The data and analytics company reports on the anticipated uptake of Humira (adalimumab) biosimilars in the EU once they are launched in 2018.
May 03, 2018
The companies will partner to develop smart connected monitoring and support solutions for injectable drugs.
May 02, 2018
Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the DPI formulation.
Determining the right process conditions for a freeze-drying cycle requires an understanding of the effect of each step on the drug product.
Airflow visualization studies, or smoke studies, confirm unidirectional airflow patterns in an aseptic processing facility.
Public health authorities and the biomedical research community are seeking new strategies to address global health threats.
A skilled workforce is needed to deliver on technology’s promising medical advances.